These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Diffusion of gentamicin and tobramycin in the plasma and ascitic fluid of cirrhotic patients. Influence of the route of administration]. Lapalus P; Bertrand F; Chabert JM; Bocquet JP; Delmont J Therapie; 1983; 38(3):247-54. PubMed ID: 6612661 [No Abstract] [Full Text] [Related]
3. [Prolactin in plasma and ascitic fluid in hepatic cirrhosis. Its relation to plasma and urinary electrolytes]. Ostolaza Vázquez JM; Jimeno Carruez A; Lapeña Villarroyo G; Vallecillo Sande MA; Ibañes Jalón E; Almaraz Quintana C Rev Esp Enferm Apar Dig; 1986 Apr; 69(4):205-9. PubMed ID: 3523651 [No Abstract] [Full Text] [Related]
4. [Comparison of biochemical parameters of the blood and ascitic fluid in hepatic cirrhosis]. Martínez Ballarín E; Escanero Marcén JF; Nuviala Mateo R; Araiz Burdio JJ; Martínez-Berganza Asensio A Rev Esp Enferm Apar Dig; 1986 Mar; 69(3):245-8. PubMed ID: 3704288 [No Abstract] [Full Text] [Related]
5. Concentrations of gentamicin in ascitic fluid after intravenous infusion. Fevery J; Zachee P; Verbist L Neth J Med; 1983; 26(7):191-2. PubMed ID: 6633753 [No Abstract] [Full Text] [Related]
6. [Diffusion of gentamicin into infected ascitic fluid in cirrhotic patients]. Latrive JP; Messerschmitt C; Preux MC Gastroenterol Clin Biol; 1984 Oct; 8(10):767-8. PubMed ID: 6526231 [No Abstract] [Full Text] [Related]
7. Fibrinolytic characteristics and their significance in malignant, tuberculous and cirrhotic pleural and ascitic fluids. Lu XG; Mao JS; Tong JF; Zhu L; Liu J; Gong XB; Huang J Int J Lab Hematol; 2007 Apr; 29(2):132-8. PubMed ID: 17474886 [TBL] [Abstract][Full Text] [Related]
8. The influence of ascites on the pharmacokinetics of amikacin. Lanao JM; Dominguez-Gil A; Macias JG; Diez JL; Nieto MJ Int J Clin Pharmacol Ther Toxicol; 1980; 18(2):57-61. PubMed ID: 7372376 [TBL] [Abstract][Full Text] [Related]
9. Influence of ascites on tobramycin pharmacokinetics. Sampliner R; Perrier D; Powell R; Finley P J Clin Pharmacol; 1984 Jan; 24(1):43-6. PubMed ID: 6707233 [TBL] [Abstract][Full Text] [Related]
10. Spontaneous bacterial peritonitis results in oxidative and nitrosative stress in ascitic fluid. Natarajan SK; Mukhopadhya A; Ramachandran A; Amalanathan S; Kurian G; Balasubramanian KA J Gastroenterol Hepatol; 2007 Feb; 22(2):177-81. PubMed ID: 17295868 [TBL] [Abstract][Full Text] [Related]
11. Bradykinin in the ascitic fluid of patients with liver cirrhosis. Cugno M; Salerno F; Nussberger J; Bottasso B; Lorenzano E; Agostoni A Clin Sci (Lond); 2001 Dec; 101(6):651-7. PubMed ID: 11724653 [TBL] [Abstract][Full Text] [Related]
12. Are ascitic electrolytes usable in cirrhotic patients? Correlation of sodium, potassium, chloride, urea, and creatinine concentrations in ascitic fluid and blood. Nguyen-Khac E; Thevenot T; Capron D; Dharancy S; Paupart T; Thabut D; Tiry C Eur J Intern Med; 2008 Dec; 19(8):613-8. PubMed ID: 19046728 [TBL] [Abstract][Full Text] [Related]
13. [The importance of the biochemical examination of ascitic fluid]. Vladár L; Hyrdel R; Hendrich F; Katuscák I Bratisl Lek Listy; 1985 Aug; 84(2):165-9. PubMed ID: 4027729 [No Abstract] [Full Text] [Related]
14. [Dynamics of ascitic fluid in decompensated cirrhosis]. Milani A; Mazzone M; Rossi L Recenti Prog Med; 1999 Feb; 90(2):94-9. PubMed ID: 10208100 [TBL] [Abstract][Full Text] [Related]
15. The presence of glucagon in ascitic fluid in cirrhotic patients. Kabadi UM; Uddinn MS; Eisenstein AB J Endocrinol Invest; 1983 Jun; 6(3):229-34. PubMed ID: 6352794 [No Abstract] [Full Text] [Related]
16. Study on ascitic fluid complement 3 level in cirrhotic patients with spontaneous bacterial peritonitis and without spontaneous bacterial peritonitis. Mustafa G; Khan M; Alam K; Rahman S; Ahmad N; Alam S; Ahmed S Hepatogastroenterology; 2007; 54(79):1905-7. PubMed ID: 18251125 [TBL] [Abstract][Full Text] [Related]
17. Effects of intravenous infusion of autogenous ascitic fluid and tolbutamide therapy on protein and electrolyte metabolism in decompensated cirrhosis of the liver. Misra SS; Teotia SP; Tandon RK J Assoc Physicians India; 1968 Aug; 16(8):475-88. PubMed ID: 5700152 [No Abstract] [Full Text] [Related]
18. [Studies on the treatment of ascitic fluid with hemodialysis devices]. Petrella E; Romagnoni M; Fellin G; Gentile M Minerva Nefrol; 1972; 19(4):265-8. PubMed ID: 4681103 [No Abstract] [Full Text] [Related]
19. Peritoneal fluid adipokines: ready for prime time? Wiest R; Leidl F; Kopp A; Weigert J; Neumeier M; Buechler C; Schoelmerich J; Schäffler A Eur J Clin Invest; 2009 Mar; 39(3):219-29. PubMed ID: 19260952 [TBL] [Abstract][Full Text] [Related]
20. [Glucose and insulin in the blood and ascitic fluid after oral administration of glucose in hepatic cirrhosis]. Greco AV; Rebuzzi AG; Altomonte L; Manna R; Ghirlanda G Minerva Dietol Gastroenterol; 1982; 28(2):133-6. PubMed ID: 7048132 [No Abstract] [Full Text] [Related] [Next] [New Search]